BackEnzolytics Overview

Enzolytics Receivables

Enzolytics's receivables is $5.2K.

Get informed when a big investor buys or sells

+ Follow
Receivables
$5177.00
↑ 0.00% YoYΔ $0.00 vs prior year quarter

Peer trimmed avg / median

Loading

Enzolytics Receivables History

Loading

Enzolytics vs. peers: Receivables Comparison

Loading

Enzolytics Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Enzolytics (ENZC) FAQ

Enzolytics (ENZC) currently reports a receivables of $5.2K as of March 2026. That compares with $5.2K in the prior-year period — up 0.0% year over year. Use the charts on this page to explore Enzolytics's receivables history and peer comparisons.

Enzolytics's receivables was unchanged from $5.2K to $5.2K — essentially flat versus a year earlier (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Enzolytics reported $5.2K in receivables as of March 2026. That compares with $5.2K in the prior-year period — up 0.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $5.2K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Enzolytics, and consider following ENZC for alerts when major investors trade the stock.

Enzolytics is classified in the Healthcare sector. On receivables, it currently shows $5.2K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ENZC with unrelated industries.